Loading clinical trials...
Loading clinical trials...
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza.
Conditions
Interventions
Peramivir
Placebo
Locations
96
United States
Physical Express
Millbrook, Alabama, United States
Alabama Family Medical Center
Tuscaloosa, Alabama, United States
HOPE Research Institute
Phoenix, Arizona, United States
Clopton Clinic
Jonesboro, Arkansas, United States
Research Solutions, LLC
Jonesboro, Arkansas, United States
Kevin Adkins, MD
Mountain Home, Arkansas, United States
Start Date
January 1, 2008
Primary Completion Date
February 1, 2008
Completion Date
February 1, 2008
Last Updated
March 17, 2021
NCT01386424
NCT07169318
NCT07291635
NCT06599658
NCT06094010
NCT06753474
Lead Sponsor
BioCryst Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions